Home » Norbrook re-launches Enroflox 100 to fight BRD in cattle

Norbrook re-launches Enroflox 100 to fight BRD in cattle

February 17, 2014

The product is approved for the treatment of Bovine Respiratory Disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somnus in beef and non-lactating dairy cattle.

The global veterinary pharmaceutical company says the new BRD treatment antibiotic has the same active ingredient and formulation as Baytril 100 (enrofloxacin) and is approved in cattle for multi-day use only.

It will be available from veterinarians in 100 mL and 250 mL bottles to fit any size operation.

—From Norbrook news release

KEYWORDS legacy

TOPICS Progressive Cattle

BUYER'S GUIDE

VISIT OUR BUYER’S GUIDE

With more than 80 patents and more than 20 inventions specifically designated to animal agriculture, we lead the way in providing advanced, comprehensive and integrated animal management systems and solutions.

Established in December 1982, American Animal Health, Inc. (AAH) has been a trusted partner for cattlemen for over 40 years. We specialize in supporting livestock health through our commercial bacterin-toxoid and autogenous bacterin services.

For decades, ranchers and producers across the United States have relied on American Stockman® nutritional products (made in the U.S. by Compass Minerals) for optimum livestock health and performance. A wide variety of plain salt and specialty ...